Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An HIV-negative writer asks: Why does resistance persist to the “Undetectable = Untransmittable” message?
An update from the Trump administration’s NHAS Federal Interagency Workgroup.
A researcher responds to expanded approval of Truvada as pre-exposure prophylaxis by the Food and Drug Administration.
A guide from the Centers for Disease Control and Prevention (CDC) for state and local health departments.
HIV groups ask: If Silence=Death, where is the HIV community’s voice resisting the war against immigrants in the United States?
Building a diverse biomedical sciences workforce is a critical step in reducing the burden of cancer for an increasingly diverse America.
Funders Concerned About AIDS (FCAA) issues a call for data.
An HIV advocate shares his thoughts about an essay by activist, author and blogger Mark S. King.
Experts respond to CDC’s recently published HIV Surveillance Supplemental Report.
Ideally, all patients with advanced cancers would be in clinical trials. Until then, the right to try is an option we all should have.
Right to Try bills attack the one agency tasked with verifying the safety and efficacy of medications.
An open letter by more than 200 HIV scientists, researchers and clinicians denouncing the deterioration of U.S. evidence-based policymaking.
The chair of HIV Medicine Association (HIVMA) responds to Trump’s budget proposal.
The yearlong effort, “#StigmaStops,” launches on Zero Discrimination Day, March 1. Here’s how you can get involved.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.